CAMBRIDGE, Mass. - Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company is scheduled to present at the J.P. Morgan 2018 Healthcare Conference in San Francisco on Tuesday, January 9, 2018at 11:30 a.m. PT (2:30 p.m. ET), followed by a Q&A session.
A live webcast of the presentation and Q&A session can be accessed on the investor page of Sage's web
RelSci News & Alerts gets you: